Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1462 participants.
Also called NCT01268371
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,462 participants
- Registry
-
NCT01268371
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT01268371. Randomized; single masking; primary purpose treatment. Start 2010-12 (registry gives no type); primary completion 2015-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents
- Acronym
- BESS
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Promus Element, Boston Scientific Corporation
- Intervention (Device)
- Nobori, Terumo Corporation (Japan)
- Lead sponsor
- Ajou University School of Medicine
Record details
- Record id
cardio:ct-nct01268371- Content hash
034fc92e1371359d84aeee61c7799c50eaa05bcd7028f202fa2109c427d90a96